Introduction: The DTP vaccine market, encompassing diphtheria, pertussis, and tetanus, exhibited a valuation of $4,758.8 million in 2019, with projections anticipating growth to $7,054.4 million by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback